Matches in Wikidata for { <http://www.wikidata.org/entity/Q65546448> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q65546448 description "clinical trial" @default.
- Q65546448 description "ensayu clínicu" @default.
- Q65546448 description "klinisch onderzoek" @default.
- Q65546448 description "клінічне випробування" @default.
- Q65546448 name "Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site" @default.
- Q65546448 name "Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site" @default.
- Q65546448 type Item @default.
- Q65546448 label "Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site" @default.
- Q65546448 label "Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site" @default.
- Q65546448 prefLabel "Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site" @default.
- Q65546448 prefLabel "Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site" @default.
- Q65546448 P1050 Q65546448-997D937B-BBEB-48CA-B297-DB6C0DEA774B @default.
- Q65546448 P1132 Q65546448-B251449F-1305-43E5-B5A8-4F8125D9B91B @default.
- Q65546448 P1476 Q65546448-384FCA52-997F-4C84-863C-CE85CDBBB16E @default.
- Q65546448 P17 Q65546448-FF67124E-022D-4CC6-A8FA-4E937514B20B @default.
- Q65546448 P2899 Q65546448-A521564F-0D4C-48E9-81A0-F54EDA7FB589 @default.
- Q65546448 P3098 Q65546448-329494CD-DE62-47B9-ACFD-498A70FFD391 @default.
- Q65546448 P31 Q65546448-07931FF9-652A-4BE2-A6A2-472C857AF4AC @default.
- Q65546448 P4844 Q65546448-3CC9F67E-8FCD-47FA-9C3C-9E7EF86DCCC4 @default.
- Q65546448 P4844 Q65546448-CF24EB30-7028-4036-BA00-FE2F713619A6 @default.
- Q65546448 P4844 Q65546448-F4DE4B42-A65E-4290-B5CA-862239004914 @default.
- Q65546448 P4844 Q65546448-F920BD87-E333-4116-9329-0852EA1E64B3 @default.
- Q65546448 P580 Q65546448-FD29B64C-AF6A-4CDB-AF1E-0F8270B77D70 @default.
- Q65546448 P582 Q65546448-9328C23B-7B16-4089-A0FC-B0784126EA37 @default.
- Q65546448 P6099 Q65546448-A30F0F2A-A92C-4970-802F-6066948625B3 @default.
- Q65546448 P6153 Q65546448-172BE836-8E90-48A6-971D-D6DEFED82F17 @default.
- Q65546448 P6153 Q65546448-8B320409-E48B-4693-8AE6-937BEF80771F @default.
- Q65546448 P6153 Q65546448-AC03401F-1FD7-4DF8-931F-DF567AEABD72 @default.
- Q65546448 P6153 Q65546448-D5E97AB1-4AA9-4DDD-8572-FB101547F255 @default.
- Q65546448 P8363 Q65546448-F2BAD0D6-3FA4-4F69-AB87-FDD8F20BBE00 @default.
- Q65546448 P1050 Q33525 @default.
- Q65546448 P1132 "+198" @default.
- Q65546448 P1476 "A Randomized, Phase III Comparison of Gemcitabine/Irinotecan Followed by IRESSA Versus Paclitaxel/Carboplatin/Etoposide Followed by IRESSA in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site" @default.
- Q65546448 P17 Q30 @default.
- Q65546448 P2899 "+18" @default.
- Q65546448 P3098 "NCT00193596" @default.
- Q65546448 P31 Q30612 @default.
- Q65546448 P4844 Q27260984 @default.
- Q65546448 P4844 Q412197 @default.
- Q65546448 P4844 Q415588 @default.
- Q65546448 P4844 Q423762 @default.
- Q65546448 P580 "2003-09-01T00:00:00Z" @default.
- Q65546448 P582 "2008-09-01T00:00:00Z" @default.
- Q65546448 P6099 Q42824827 @default.
- Q65546448 P6153 Q30280268 @default.
- Q65546448 P6153 Q43896830 @default.
- Q65546448 P6153 Q46992910 @default.
- Q65546448 P6153 Q4821833 @default.
- Q65546448 P8363 Q78089383 @default.